Full-Time

Strategic Sourcing Associate Director

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$143.2k - $214.8k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

This role requires a hybrid work schedule: 3 days in office on a weekly basis.

Category
Procurement & Sourcing
Operations & Logistics
Required Skills
Power BI
Tableau
Data Analysis
Requirements
  • Deep understanding of Category Management within specific areas of expertise; able to manage and drive all aspects of Strategic Sourcing including strategy development, RFx execution, negotiation, contract execution, supplier performance management, and business stakeholder management.
  • Expertise in complex supplier negotiations and supplier management activities.
  • Strong analytical capabilities (data analysis and benchmarking research); expertise working with data analytical/reporting tools such as Power BI, Tableau, etc. Able to generate necessary data and reports to support their activities.
  • Sound understanding and demonstrated use of Continuous Improvement tools (including Pareto Charts, Flow Diagrams, etc.) to drive process improvements.
  • Strong project management and organizational skills.
  • Strong written and verbal communication skills; ability to clearly articulate opinions in concise and persuasive manner. Comfortable with public speaking with various audience levels, including Sr. Management.
  • Strong knowledge and understanding of contract law, including all terms and conditions; seen as a trusted partner from Legal colleagues to provide valuable insight to potential risks across all types of agreements (i.e. CDAs, MSAs, etc).
  • Ability to work in collaborative, team environment; ability to cultivate and maintain effective business partner relationships through earned respect and trust.
  • Proficient in Microsoft Office, strong knowledge of ERP systems, and related e-Sourcing tools, including business intelligence and reporting platforms.
Responsibilities
  • Business Partnering – develop strong, trusting, and influential relationships with stakeholders, understand business objectives, bring supplier and marketplace expertise, collaborate on multi-year strategic and operational plans, and drive business outcomes.
  • Global Category Management – Category SME - including the development and management of category and sourcing strategies, management of strategic supplier relationship and performance management, in addition to tactical RFx activities.
  • Sourcing Strategy Development – Co-develop and implement sourcing strategies with the business unit to enable development and commercialization of small molecule portfolio. This includes identifying and selecting suppliers, negotiating contracts, influence network strategy and managing supplier relationships.
  • Supplier Relationship Management - Build and maintain strong relationships with key CDMO/suppliers. Negotiate contracts/agreements to secure favorable terms while ensuring compliance with quality standards and regulatory requirements.
  • Risk Mitigation - Assess and mitigate risks associated with suppliers, including supply chain disruptions, quality issues, and regulatory compliance. Develop contingency/resiliency plans and alternative sourcing options to minimize potential impact on production schedules.
  • Cost Optimization - Drive cost optimization initiatives through supplier negotiations, volume leverage, and process improvements. Identify opportunities for cost savings without compromising product quality or reliability of supply.
  • Cross-functional Collaboration - Work closely with cross-functional teams, including R&D, external manufacturing, quality control, vendor quality and regulatory affairs, to align sourcing activities with production schedules, product specifications, and regulatory requirements.
  • Market Analysis - Stay informed about market trends, supplier capabilities, and emerging technologies. Conduct market analysis and supplier assessments to identify new opportunities and risks.
  • Continuous Improvement- Implement continuous improvement initiatives to streamline sourcing processes, enhance efficiency, and drive operational excellence. Leverage data analytics and performance metrics to monitor supplier performance and identify areas for improvement.
  • Financials – Support annual budget process. Provide cost guidance to inform to LRP (Long Range Planning). Evaluate Bill of Material (BOMs) and understand total COGs to identify opportunities and risks.
Desired Qualifications
  • Minimum of 7-10 years of experience in strategic sourcing, procurement, or supply chain management, with a focus on API sourcing within the pharmaceutical, biologic or cell and gene industry.
  • Bachelor's degree in chemistry, or an applicable scientific field desired.
  • Proven track record of negotiating contracts, managing supplier relationships, and driving cost savings initiatives.
  • Strong analytical and problem-solving skills, with the ability to assess risks and develop effective mitigation strategies.
  • Excellent communication and interpersonal skills, with the ability to collaborate effectively across functions and levels of the organization.
  • Understanding of raw material specifications, quality requirements, and regulatory standards relevant to current Good Manufacturing Practices.
  • Familiarity with regulatory requirements, quality standards, and best practices in the pharmaceutical industry, including Good Manufacturing Practices (GMP) and ISO standards.
  • Ability to travel as needed to meet with suppliers, visit manufacturing facilities, and attend industry conferences and events.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • EU approval for expanded cystic fibrosis treatment label boosts market penetration in Europe.
  • Partnership with Arbor Biotechnologies positions Vertex at the forefront of innovative treatments.
  • Recent investments indicate strong investor confidence in Vertex's growth potential.

What critics are saying

  • Recent layoffs suggest financial or strategic challenges impacting operational capabilities.
  • Discontinuation of diabetes asset indicates difficulty diversifying beyond cystic fibrosis.
  • Reliance on key products like ivacaftor makes Vertex vulnerable to market fluctuations.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's collaboration with Arbor Biotechnologies advances novel ex vivo engineered cell therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Pharmalive
Jun 11th, 2025
After axing diabetes asset, Vertex lays off 140 staff

After axing diabetes asset, Vertex lays off 140 staff.

PBN
Jun 10th, 2025
Vertex Pharmaceuticals to lay off 125 R.I. employees

PROVIDENCE - Vertex Pharmaceuticals Inc. is laying off 125 people in Rhode Island, according to a WARN notice filed with the R.I. Department of Labor and Training on June 8.

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.